A phase 1/2 trial of a monoclonal antibody targeting fucosyl GM1 in relapsed/refractory small cell lung cancer (SCLC): Safety and preliminary efficacy Meeting Abstract
| Authors: | Chu, Q. S. C.; Markman, B.; Leighl, N.; Krug, L.; Rudin, C.; Lathers, D.; Basciano, P.; Fracasso, P. M.; Kollia, G.; Phillips, P.; Kolaitis, G.; Williams, D.; Jackson, J.; Ready, N. |
| Abstract Title: | A phase 1/2 trial of a monoclonal antibody targeting fucosyl GM1 in relapsed/refractory small cell lung cancer (SCLC): Safety and preliminary efficacy |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi494 |
| Language: | English |
| ACCESSION: | WOS:000393913000514 |
| DOI: | 10.1093/annonc/mdw389.05 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1427PD -- Source: Wos |
